Hypertension Diagnostics, Inc.


	Hypertension Diagnostics Announces Fiscal Year 2006 Results ST. PAUL, MN – September 28, 2006 – Hypertension Diagnostics, Inc. (OTC: HDII.OB), today announced audited financial results for the fiscal year ended June 30, 2006. Revenue for fiscal 2006 totaled $1,789,546 compared to $1,182,005 in the prior year ended June 30, 2005, which represents a 51% increase. The Company incurred a net loss of $1,272,742 for fiscal 2006, or $(0.04) per share, compared with a net loss of $1,455,228 for fiscal 2005, or $(0.05) per share. Included in the net loss for fiscal 2006 are total non-cash charges (expenses associated with stock compensation, depreciation, stock options) of $669,506. Included in the net loss for fiscal 2005 are total non-cash charges of $337,976. The Company reported a cash balance on June 30, 2006 of $1,722,913.
	Fourth quarter revenue of $295,536 for fiscal 2006 versus $421,335 for fiscal 2005 represented a 30% decline. Revenue for the fourth quarter of fiscal 2006 decreased 48% compared with $571,988 for the third quarter of fiscal 2006. “As previously reported, the disappointing financial results are due to a decline in the number of customers converting their CVProfilor rental agreements to purchases and the longer than anticipated time it has been taking for customers to make a purchase decision– a factor likely to continue for the next few quarters,” said Mark N. Schwartz, Chairman and CEO. Forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company wishes to caution readers not to place undue reliance on any forward-looking statements and to recognize that the statements are not a prediction of actual future results. Actual results could differ materially from those presented and anticipated in the forward-looking statements due to the risks and uncertainties set forth in the Company’s 2004 Annual Report on Form 10-KSB, and subsequent Quarterly Reports on Form 10-QSB, all of which were filed with the U.S. Securities and Exchange Commission, as well as others not now anticipated. View PDF file: FY 2006 Results CVProfilor is a registered trademark of Hypertension Diagnostics, Inc. Hypertension Diagnostics, HDI/PulseWave, PulseWave and CVProfile are trademarks of Hypertension Diagnostics, Inc. All rights reserved. Website: www.HDII.com Contact: Mark Schwartz, CEO 651-687-9999 Return to the Main HDI Newsroom Back to Top

Copyright © 2010 Hypertension Diagnostics, Inc Last revised Wednesday June 23, 2010 HDI Legal Information